-
Recombinant Human IL-6 Assay Workflows
2026-09-17
Build controlled cytokine perturbation experiments around Recombinant Human IL-6, Tag Free for cell-state, developmental, and metabolism-focused assays. This practical workflow emphasizes dose finding, factorial controls, morphology, and metabolic readouts rather than assuming that IL-6 directly explains WDR36 biology.
-
Cardiogreen (Indocyanine Green) Workflows
2026-09-16
Cardiogreen (Indocyanine Green) links vascular diagnostics with practical near-infrared therapy workflows, from perfusion imaging to phototherapy-based cell assays. This guide translates its optical and biochemical properties into reproducible protocols, OSCC immunotherapy assay choices, and troubleshooting strategies.
-
Filipin III: Reading Cholesterol in MASLD
2026-09-15
Filipin III offers a cholesterol-sensitive view of membrane organization, but its signal must be interpreted as a biophysical phenotype rather than a simple concentration readout. This article connects membrane cholesterol visualization with caveolin-1, ER stress, and pyroptosis in MASLD while outlining assay controls and practical limitations.
-
Isradipine (Dynacirc) Research Workflows
2026-09-15
Isradipine (Dynacirc) provides a practical L-type calcium-channel perturbation strategy for vascular, neuronal, and calcium-imaging workflows. This guide connects preparation and assay execution with the reference study’s warning that calcium-channel pharmacology depends on cell type, voltage, kinetics, and orthogonal validation.
-
WAY-100635 in Pain-Circuit Assays
2026-09-14
WAY-100635 provides a selective way to test whether 5-HT1A signaling contributes to pain, affect, and serotonergic circuit phenotypes. This workflow connects receptor binding and functional antagonism with behavioral pharmacology and imaging-oriented experiments inspired by recent cannabidiol research.
-
Lumiracoxib as a Causal COX-2 Assay Probe
2026-09-14
Lumiracoxib can do more than suppress inflammatory signaling: it can help researchers test when and how COX-2 controls ischemia, revascularization, and tissue repair. This guide translates venom-induced muscle injury findings into a rigorous, time-resolved assay strategy.
-
Puerarin, Gut Microbiota, and Adipose Thermogenesis
2026-09-13
This 2026 Phytotherapy Research study links puerarin’s metabolic benefits in type 2 diabetes mice to coordinated changes in gut microbiota, fecal metabolites, brown-fat activity, and white-fat browning. Its multi-layered design supports a microbiota–SCFA–GLP-1 and PI3K/AKT/PPARγ framework, while also highlighting the need for mechanistic validation beyond association-based measurements.
-
Verapamil as a Probe in Urothelial Hypoxia
2026-09-12
Prolonged hypoxia can shift urothelial cells from adaptation toward ROS-linked TXNIP/NLRP3 inflammation. This article positions Verapamil ((±)-Verapamil) as a mechanistically informative probe while defining the controls, translational opportunities, and limitations needed for rigorous bladder outlet obstruction research.
-
MRT68921 ULK1 Kinase Inhibitor Workflow
2026-09-12
MRT68921 enables direct, time-resolved interrogation of ULK1/2-dependent autophagy initiation through ATG13 phosphorylation and LC3 flux readouts. This workflow pairs pharmacological inhibition with energy-stress controls to distinguish pathway-specific effects from nutrient, solvent, and assay artifacts.
-
Netarsudil: From ROCK Biology to RNA Delivery
2026-09-11
Explore how Netarsudil (AR-13324) connects ROCK pharmacology with trabecular meshwork biology and experimental siRNA codelivery. This evidence-weighted guide focuses on assay interpretation, formulation decisions, and translational limitations.
-
Adipose-Neural Signaling in Cardiac Arrhythmia
2026-09-11
Fan et al. established a stem cell-based coculture model showing that adipocyte-derived leptin activates sympathetic neurons, increases neuropeptide Y release, and promotes cardiomyocyte arrhythmia through Y1R, NCX, and CaMKII signaling. The study provides a mechanistic framework for linking epicardial adipose tissue to atrial fibrillation while highlighting the need to distinguish Y1R-mediated cardiac effects from Y2R-directed pharmacology.
-
Magnetic Stimulation Targets GABRE in Schizophrenia
2026-09-10
A 2025 Molecular Psychiatry study identifies the GABAA receptor epsilon subunit, encoded by Gabre, in the left prelimbic cortex as a selective mediator of schizophrenia-like behaviors in mice. By combining targeted magnetic stimulation with genetic knockdown and conditional knock-in models, the researchers connect GABRE regulation to synaptic plasticity and p62/SQSTM1-dependent handling of GABARAP proteins.
-
Reparixin as a CXCR1/2 Inhibitor in IL-8 Studies
2026-09-10
Reparixin provides a practical pharmacological way to test how CXCL8–CXCR1/2 signaling shapes neutrophil migration, inflammatory injury, and IL-8-linked tumor biology. This guide connects receptor-proximal assays with MRSA extracellular-vesicle models, highlighting workflow design, controls, and troubleshooting priorities.
-
Primary Antibody Dilution Buffer for PCNSL Biology
2026-09-09
Primary Antibody Dilution Buffer K1200 helps translate single-cell insights from PCNSL into interpretable IHC, ICC, and ISH workflows. This guide connects buffer chemistry with spatial biology, assay controls, and the limits of inferring SLC2A5 activity from staining alone.
-
Hyaluronic Acid Sodium Salt for siRNA Workflows
2026-09-09
Hyaluronic acid sodium salt combines extracellular-matrix relevance with a practical coating strategy for peptide nanoparticles, making it useful in siRNA delivery, immune-cell assays, and organoid models. This guide translates a recent TDRD9-targeting lung-injury study into formulation, assay, and troubleshooting decisions without overstating what has been experimentally validated.